California Cancer Reporting System Standards, Volume III

IF1211: TNM Path T, Path Size, Site Spec – Ed 7 (SEER)

OWNER

SEER

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

Tumor Size Pathologic [NAACCR #754]

TNM Path T [NAACCR #880]

Date of Diagnosis [NAACCR #390]

Primary Site [NAACCR #400]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3 [NAACCR# 523]

CS Site-Specific Factor 10 [NAACCR #2864]

CS Site-Specific Factor 25 [NAACCR #2879]

Grade [NAACCR #440]

Age at Diagnosis [NAACCR #230]

Sex [NAACCR #220]

Type of Reporting Source [NAACCR# 500]

TABLE

AC7G2016.DBF

PATHNNUM.DBF

MESSAGE

IF1211: Path T of [value] is not consistent with Tumor Size Pathologic of [value]

specification

This edit is skipped if any of the following conditions are true:

Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid
Type of Reporting Source = 7 (Death Certificate Only)
Histologic Type ICD-O-3 is blank
Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
Site/Histology where Path T is not dependent on pathologic tumor size
TNM Path T is blank or 88
Tumor Size Pathologic is blank or 999
TNM Edition Number not = 07, U7

TNM Path T may be blank. If entered, it will be edited site-specifically. A pT category entered in TNM Path T will be compared to Tumor Size Pathologic. An edit failure will be returned if the pathologic tumor size is outside the range of tumor size for the listed pT category. "989", "989 millimeters or larger", is the highest possible size for Tumor Size Pathologic. 990 (microscopic focus) will be accepted for p1 (p1A, p1MI) for all sites/histologies included in this edit.

The site-specific TNM Pathologic T values with the corresponding clinical tumor size in millimeters are listed below. The number next to each site title indicates the respective chapter in the AJCC Cancer Staging Manual, Edition 7. The list includes only those sites/histology groups where pathologic T is based on pathologic tumor size. The site/histology groups are identified by site and histology in the edits Primary Site, AJCC Stage Group 2016 - Ed 7 (COC), Primary Site, Stage Group 2016 - Ed 7 (NPCR), and Primary Site, Stage Group 2016 - Ed 7 (SEER). Subdivision of the 4A site/histology group, Oropharynx and Hypopharynx, was required for this edit; the site codes for Hypopharynx were removed to site group 4E.

Lip and Oral Cavity

TNM T	1	2	3
Tumor Size Path	001-020,990	021-040	041-989

Pharynx

4A. Oropharynx and Hypopharynx

Division for T Category

4A. Oropharynx only

Sites: C019, C024, C051-C052, C090-C091, C098-C099, C100, C102-C104, C108-C109

TNM T	1	2
Tumor Size Path	001-020,990	021-040

4E. Hypopharynx

Sites: C129, C130-C139

TNM T	1
Tumor Size Path	001-020,990

4D. Oropharynx

TNM T	1	2
Tumor Size Path	001-020,990	021-040

Major Salivary Glands

TNM T	1	2
Tumor Size Path	001-020,990	021-040

Thyroid Gland

8A. Thyroid: Papillary/follicular, age less than 045

8B. Thyroid: Papillary/follicular, age greater than or equal 045 but not 999

8C. Thyroid: Papillary/follicular, age equal 999 (unknown)

8D. Thyroid: Medullary

TNM T	1	1A	1B	2
Tumor Size Path	001-020,990	001-020,990	011-020	021-040

Appendix

13B. Appendix: Carcinoid

TNM T	1	1A	1B
Tumor Size Path	001-020,990	001-020,990	011-020

Anus

TNM T	1	2	3
Tumor Size Path	001-020,990	021-050	051-989

Gastrointestinal Stromal Tumor (GIST)

16A. GIST: Gastric

16B. GIST: Small Intestine

TNM T	1	2	3	4
Tumor Size Path	001-020,990	021-050	051-100	101-989

Neuroendocrine Tumors (NET)

17A. NET: Stomach

17B. NET: Small Intestine

TNM T	1
Tumor Size Path	001-010,990

17D. NET: Ampulla

TNM T	1	2
Tumor Size Path	001-010,990	011-989

Exocrine and Endocrine Pancreas

TNM T	1	2
Tumor Size Path	001-020,990	021-989

Lung

TNM N	1	1A	1B	2A	2B
Tumor Size Path	001-030,990	001-020,990	021-030	001-050,990	051-070

Bone

TNM T	1	2
Tumor Size Path	001-080,990	081-989

Soft Tissue Sarcoma

TNM T	1	2
Tumor Size Path	001-050,990	051-989

Cutaneous Squamous Cell Carcinoma and other Cutaneous Carcinomas

TNM T	1
Tumor Size Path	001-020,990

Merkel Cell Carcinoma

TNM T	1	2	3
Tumor Size Path	001-020,990	021-050	051-989

Breast

TNM N	1	1M	1A	2B	1C	2	3
Tumor Size Path	001-020,990	001-001,990	001-050,990	005-010	011-020	021-050	051-989

Kidney

TNM N	1	1A	1B	2	2A	2B
Tumor Size Path	001-070,990	001-040,990	041-070	071-989	071-100	101-989

Adrenal

47A. Adrenal Cortex

47B. Adrenal Cortical Carcinoma

TNM T	1	2
Tumor Size Path	001-050,990	051-989

Conjunctiva

TNM T	1	2
Tumor Size Path	001-050,990	006-989

Carcinoma of the Lacrimal Gland

TNM T	1	2	3
Tumor Size Path	001-020,990	021-040	041-989

Sarcoma of the Orbit

TNM T	1	2
Tumor Size Path	001-015,990	016-989

historical changes

In the SEER*Edits software, the title of this edit is: IF618.
08/2016	Per NAACCR v16, new edit added.
09/2016	Per NAACCR v16A: Corrected logic for first INLIST of primary sites for site/histology group 57A, 000-419-440 changed to 000-440 Corrected Edit Logic to include 9727 as lymphoma rather than lymphoma/leukemia code, to delete 9728-9729 as obsolete codes Added Group 57C, C420, C421, C424, 9811-9818, 9837,to Edit Logic.
11/2016	Per NAACCR v16B: Description updated to reference 3 edits where site/histology groups are identified: Primary Site, AJCC Stage Group 2016 - Ed 7 (COC), Primary Site, Stage Group 2016 - Ed 7 (NPOCR), and Primary Site, Stage Group 2016 - Ed 7 (SEER). Description corrected to show size range of 001-050, 990 for group 025, p2A, Lung. Edit logic updated to pass 990 for p2A, Lung Table referenced by edit updated to include size range of 001-050 for p2A, Lung Corrected edit logic for assigning site/histology group 011 to group 10B or 999 based on histology and CS Site-Specific Factor 25.
03/2017	Per NAACCR v16D: Added skip if TNM Edition Number not = 07,U7. Logic formatting corrected(edit returns not changed).